BIT 0.00% 2.7¢ biotron limited

Novavax to commence COVID-19 vaccine trial with Nucleus...

  1. 7 Posts.
    lightbulb Created with Sketch. 8

    Novavax to commence COVID-19 vaccine trial with Nucleus Network

    15th April 2020

    US-based clinical-stage biotechnology company Novavax (NASDAQ: NVAX) has called upon the expertise of Australian based Nucleus Network (Nucleus) to commence Phase 1 clinical trials for its COVID-19 vaccine trials.


    Beaten to the punch?


    Last edited by clayzee: 15/04/20
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.